The endosomal pathway in Parkinson's disease

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting dopaminergic neurons.
• It is characterized by movement difficulties and Lewy body formation.
• Clinical heterogeneity of PD contrasts with emerging unifying biochemical pathways.

Purpose of the Study:

• To review evidence linking Parkinson's-associated genetic mutations to endosomal pathway defects.
• To explore how these defects contribute to alpha-synuclein misfolding and Lewy body formation.
• To propose a model for age-related susceptibility and acquired defects in PD pathogenesis.

Main Methods:

• Review of recent advances in molecular genetics and model organism studies.
• Analysis of evidence implicating specific genes (e.g., LRRK2, VPS35, GBA) in protein trafficking and degradation.
• Discussion of the role of endolysosomal pathways and ubiquitin signaling in PD.

Main Results:

• Numerous PD-associated genetic mutations disrupt protein trafficking and degradation through the endosomal pathway.
• These disruptions can lead to the accumulation and misfolding of alpha-synuclein, forming Lewy bodies.
• Neuromelanin deposition may cause age-related endolysosome depletion, increasing neuronal susceptibility to these defects.

Conclusions:

• Defects in the endosomal pathway are central to Parkinson's disease pathogenesis, linking genetic and acquired factors.
• Enzymes regulating ubiquitin signaling, like Nedd4, may bridge genetic and acquired endosomal trafficking defects.
• Understanding these pathways offers insights into potential therapeutic targets for Parkinson's disease.